KOD vs KTTA

Kodiak Sciences Inc vs Pasithea Therapeutics Corp. — Valuation Comparison 2026

KOD

Biotechnology
Kodiak Sciences Inc
Quality
4.8
out of 10
Value Trap
12
SAFE
Price
$36.12
Last close
Models
10/13
Active
VS

KTTA

Biotechnology
Pasithea Therapeutics Corp.
Quality
4.1
out of 10
Value Trap
24
SAFE
Price
$0.70
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType KOD Fair ValueKOD Upside KTTA Fair ValueKTTA Upside
Bayesian DCF Intrinsic $12.00 -66.8% $1.01 +45.1%
Earnings Power Value Intrinsic $23.98 -46.5%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $3.57 -90.1% $1.72 +147.3%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for KOD vs KTTA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

KOD vs KTTA — Which Stock Is More Undervalued?

KOD scores higher with a 4.8/10 quality rating vs KTTA's 4.1/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Kodiak Sciences Inc (KOD) and Pasithea Therapeutics Corp. (KTTA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

KOD currently trades at $36.12 with a QOC of 4.8/10, while KTTA trades at $0.70 with a QOC of 4.1/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).